Analysis Sans Fronti??res
- 1 January 2006
- journal article
- review article
- Published by Springer Nature in PharmacoEconomics
- Vol. 24 (11) , 1087-1099
- https://doi.org/10.2165/00019053-200624110-00006
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Whither trial‐based economic evaluation for health care decision making?Health Economics, 2006
- Using Value of Information Analysis to Prioritise Health ResearchPharmacoEconomics, 2006
- Management of non-ST-elevation acute coronary syndromes: how cost-effective are glycoprotein IIb/IIIA antagonists in the UK National Health Service?International Journal of Cardiology, 2005
- National Institute for Clinical Excellence and its value judgmentsBMJ, 2004
- Assessing generalisability by location in trial‐based cost‐effectiveness analysis: the use of multilevel modelsHealth Economics, 2004
- Cost‐effectiveness acceptability curves – facts, fallacies and frequently asked questionsHealth Economics, 2004
- Assessing the appropriateness of combining economic data from multinational clinical trialsStatistics in Medicine, 2003
- Are the WOSCOPS clinical and economic findings generalizable to other populations?Acta Cardiologica, 2000
- Formulary Submission Guidelines for Blue Cross and Blue Shield of Colorado and NevadaPharmacoEconomics, 1999
- Cost Effectiveness of Thrombolytic Therapy with Tissue Plasminogen Activator as Compared with Streptokinase for Acute Myocardial InfarctionNew England Journal of Medicine, 1995